Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer

被引：0
|
作者：
Xiao-Wei Li
Bing-Yu Shi
Qing-Lan Yang
Jie Wu
Hui-Min Wu
Yu-Feng Wang
Zhi-Jiao Wu
Yi-Mei Fan
Ya-Ping Wang
机构：
[1] Nanjing University,Department of Medical Genetics, Jiangsu Key Laboratory of Molecular Medicine, Medical School
来源：
BMC Cancer | / 15卷
关键词：
Alternative splicing; CDH1; Histone modifications; DNA methylation; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Hereditary Diffuse Gastric Cancer Syndrome CDH1 Mutations and Beyond
    Hansford, Samantha
    Kaurah, Pardeep
    Li-Chang, Hector
    Woo, Michelle
    Senz, Janine
    Pinheiro, Hugo
    Schrader, Kasmintan A.
    Schaeffer, David F.
    Shumansky, Karey
    Zogopoulos, George
    Santos, Teresa Almeida
    Claro, Isabel
    Carvalho, Joana
    Nielsen, Cydney
    Padilla, Sarah
    Lum, Amy
    Talhouk, Aline
    Baker-Lange, Katie
    Richardson, Sue
    Lewis, Ivy
    Lindor, Noralane M.
    Pennell, Erin
    MacMillan, Andree
    Fernandez, Bridget
    Keller, Gisella
    Lynch, Henry
    Shah, Sohrab P.
    Guilford, Parry
    Gallinger, Steven
    Corso, Giovanni
    Roviello, Franco
    Caldas, Carlos
    Oliveira, Carla
    Pharoah, Paul D. P.
    Huntsman, David G.
    JAMA ONCOLOGY, 2015, 1 (01) : 23 - 32
  • [22] Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer
    Bostjan Humar
    Francesco Graziano
    Stefano Cascinu
    Vincenzo Catalano
    Anna M Ruzzo
    Mauro Magnani
    Tumi Toro
    Tudor Burchill
    Matthias E Futschik
    Tony Merriman
    Parry Guilford
    Oncogene, 2002, 21 : 8192 - 8195
  • [23] Correlation between SNPs in CDH1 and gastric cancer in Chinese population
    Lin, Yijin
    Yuan, Jintao
    Wang, Lihui
    Wang, Lan
    Ma, Yunjia
    Wang, Yuhua
    Chen, Jianhong
    Zhao, Hong
    OPEN MEDICINE, 2015, 10 (01): : 57 - 62
  • [24] Germline CDH1 deletions in hereditary diffuse gastric cancer families
    Oliveira, Carla
    Senz, Janine
    Kaurah, Pardeep
    Pinheiro, Hugo
    Sanges, Remo
    Haegert, Anne
    Corso, Giovanni
    Schouten, Jan
    Fitzgerald, Rebecca
    Vogelsang, Holger
    Keller, Gisela
    Dwerryhouse, Sarah
    Grimmer, Donna
    Chin, Suet-Feung
    Yang, Han-Kwang
    Jackson, Charles E.
    Seruca, Raquel
    Roviello, Franco
    Stupka, Elia
    Caldas, Carlos
    Huntsman, David
    HUMAN MOLECULAR GENETICS, 2009, 18 (09) : 1545 - 1555
  • [25] The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage
    Pannone, G.
    Santoro, A.
    Feola, A.
    Bufo, P.
    Papagerakis, P.
    Lo Muzio, L.
    Staibano, S.
    Ionna, F.
    Longo, F.
    Franco, R.
    Aquino, G.
    Contaldo, M.
    De Maria, S.
    Serpico, R.
    De Rosa, A.
    Rubini, C.
    Papagerakis, S.
    Giovane, A.
    Tombolini, V.
    Giordano, A.
    Caraglia, M.
    Di Domenico, M.
    CURRENT CANCER DRUG TARGETS, 2014, 14 (02) : 115 - 127
  • [26] Regulation of alternative splicing of tau exon 10
    Wei Qian
    Fei Liu
    Neuroscience Bulletin, 2014, 30 (02) : 367 - 377
  • [27] Regulation of alternative splicing of tau exon 10
    Qian, Wei
    Liu, Fei
    NEUROSCIENCE BULLETIN, 2014, 30 (02) : 367 - 377
  • [28] Regulation of alternative splicing of tau exon 10
    Wei Qian
    Fei Liu
    Neuroscience Bulletin, 2014, 30 : 367 - 377
  • [29] CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer
    Pan, Zhiwen
    Fu, Zhixuan
    Luo, Cong
    Bao, Yejiang
    Wang, Mingli
    Cao, Wenming
    Xu, Xiaohong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2145 - 2151
  • [30] CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer
    Adib, Elio
    El Zarif, Talal
    Nassar, Amin H.
    Akl, Elie W.
    Abou Alaiwi, Sarah
    Mouhieddine, Tarek H.
    Esplin, Edward D.
    Hatchell, Kathryn
    Nielsen, Sarah M.
    Rana, Huma Q.
    Choueiri, Toni K.
    Kwiatkowski, David J.
    Sonpavde, Guru
    BRITISH JOURNAL OF CANCER, 2022, 126 (05) : 797 - 803
12345